| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 4 securities · passive | ||||||
|
Outset Medical, Inc.
13G/A
OM · 690145107
|
2.9% |
2/17/2026
Event 12/31/2025
|
||||
| PFM Health Sciences, LP | 2.9% | |||||
| PFM Health Sciences GP, LLC | 2.9% | |||||
| PFM Healthcare Growth Equity I GP, LLC | 2.9% | |||||
| Partner Asset Management, LLC | 2.9% | |||||
| Brian D. Grossman | 2.9% | |||||
|
Werewolf Therapeutics, Inc.
13G/A
HOWL · 95075A107
|
0.9% |
8/14/2025
Event 6/30/2025
|
||||
| PFM Health Sciences, LP | 0.9% | |||||
| PFM Health Sciences GP, LLC | 0.9% | |||||
| Partner Asset Management, LLC | 0.9% | |||||
| Brian D. Grossman | 0.9% | |||||
|
PMV Pharmaceuticals, Inc.
13G/A
PMVP · 69353Y103
|
0% |
8/14/2025
Event 6/30/2025
|
||||
| PFM Health Sciences, LP | 0% | |||||
| PFM Health Sciences GP, LLC | 0% | |||||
| Partner Asset Management, LLC | 0% | |||||
| Brian D. Grossman | 0% | |||||
|
ESSA Pharma Inc.
13G/A
EPIX · 29668H708
|
0% |
2/14/2025
Event 12/31/2024
|
||||
| PFM Health Sciences, LP | 0% | |||||
| PFM Health Sciences GP, LLC | 0% | |||||
| Partner Asset Management, LLC | 0% | |||||
| Brian D. Grossman | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.